What is Lm Technology?
Robert Petit, MD, Chief Scientific Officer of Advaxis, Inc. gives an overview of Advaxis' Lm Technology, which alters Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T-cells directe... Author: ASCO2017 Added: 06/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2017 Category: Cancer & Oncology Source Type: podcasts